UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Lowered by Adams Diversified Equity Fund Inc.

Adams Diversified Equity Fund Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 32,400 shares of the healthcare conglomerate’s stock after selling 2,500 shares during the quarter. Adams Diversified Equity Fund Inc.’s holdings in UnitedHealth Group were worth $18,944,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group in the 3rd quarter valued at approximately $27,000. Macroview Investment Management LLC increased its stake in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares during the period. Delos Wealth Advisors LLC increased its stake in UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the period. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group in the 2nd quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $562.13 on Wednesday. The firm has a fifty day moving average price of $582.88 and a two-hundred day moving average price of $540.32. The company has a market cap of $519.08 billion, a PE ratio of 36.62, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the company posted $6.56 EPS. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Ratings Changes

UNH has been the topic of several analyst reports. Truist Financial restated a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Cantor Fitzgerald increased their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Bank of America dropped their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.